Last Updated: November 8, 2026

Mdd Us Company Profile

« Back to Dashboard

What is the competitive landscape for MDD US

MDD US has three approved drugs.

There are three US patents protecting MDD US drugs.

Summary for Mdd Us

US Patents:	3
Tradenames:	3
Ingredients:	2
NDAs:	3

Drugs and US Patents for Mdd Us

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mdd Us	XADAGO	safinamide mesylate	TABLET;ORAL	207145-002	Mar 21, 2017	AB	RX	Yes	Yes	8,278,485	⤷ Start Trial		Y		⤷ Start Trial
Mdd Us	ONAPGO	apomorphine hydrochloride	SOLUTION;SUBCUTANEOUS	214056-001	Feb 3, 2025		RX	Yes	Yes		⤷ Start Trial				⤷ Start Trial
Mdd Us	XADAGO	safinamide mesylate	TABLET;ORAL	207145-002	Mar 21, 2017	AB	RX	Yes	Yes	8,076,515	⤷ Start Trial	Y	Y		⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for Mdd Us Drugs

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Portugal	2474521	⤷ Start Trial
Spain	2527437	⤷ Start Trial
Eurasian Patent Organization	025326	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Supplementary Protection Certificates for Mdd Us Drugs

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1613296	15C0054	France	⤷ Start Trial	PRODUCT NAME: SAFINAMIDE; REGISTRATION NO/DATE: EU/1/14/984 20150224
1613296	300752	Netherlands	⤷ Start Trial	PRODUCT NAME: SAFINAMIDE; REGISTRATION NO/DATE: EU/1/14/984 20150224
1613296	C20150033 00258	Estonia	⤷ Start Trial	PRODUCT NAME: SAFINAMIID;REG NO/DATE: EU/1/14/984 26.02.2015
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Mdd Us

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.